Biotech News

MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®

MiMedx (MDXG)MiMedxCompany update

Industry’s Most Studied Placental Allografts Appear in Nearly 100 Clinical and Scientific Publications MARIETTA, Ga., Feb. 02, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the 15 th anniversary of EPIFIX and AMNIOFIX, the Company’s placental

Related news

MiMedx

Placental Tissue Products MIMEDX develops and commercializes placental-tissue products for wound care, burns and surgery. Its processing and product portfolio are designed to provide extracellular-matrix and biologic materials that support healing and tissue repair. Wound-Care Portfolio The company has more than a decade of experience...

Recent company news

Stock data

Close
4.33 USD
Market cap
531.74M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States